This content is from: Features
Canada's new takeover regime: Watch this space
Stikeman Elliott partners analyse Canada’s new takeover bid regime and its impact on Aurora’s recent hostile bid for competitor CanniMed
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an IFLR subscriber? Login here